Latest IPA reports update at 2022-07-29: 20222021
ImmunoPrecise Antibodies Ltd. logo

ImmunoPrecise Antibodies Ltd. IPA

$ 1.32 10.55%

Country

canadaCanada

IPO year

-

Industry

-

Stock Exchange

NASDAQ GLOBAL

CEO

-

Employees in the company

-

Shares

19.7 M

Market Cap[1]

$ 26 M

EBITDA (LTM)

-

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.